165 related articles for article (PubMed ID: 17919265)
1. Polymorphism of interleukin-18 promoter influences the onset of kidney graft function after transplantation.
Kolesar L; Novota P; Krasna E; Slavcev A; Viklicky O; Honsova E; Striz I
Tissue Antigens; 2007 Nov; 70(5):363-8. PubMed ID: 17919265
[TBL] [Abstract][Full Text] [Related]
2. -174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period.
Kocierz M; Siekiera U; Kolonko A; Karkoszka H; Chudek J; Cierpka L; Wiȩcek A
Tissue Antigens; 2011 Apr; 77(4):283-90. PubMed ID: 21388350
[TBL] [Abstract][Full Text] [Related]
3. Association of G-137C IL-18 promoter polymorphism with acute allograft rejection in renal transplant recipients.
Kim CD; Ryu HM; Choi JY; Choi HJ; Choi HJ; Cho JH; Park SH; Won DI; Kim YL
Transplantation; 2008 Dec; 86(11):1610-4. PubMed ID: 19077897
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphism with allograft function in renal transplant patients.
Manchanda PK; Bid HK; Kumar A; Mittal RD
Transpl Immunol; 2006 Apr; 15(4):289-96. PubMed ID: 16635751
[TBL] [Abstract][Full Text] [Related]
5. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.
Breulmann B; Bantis C; Siekierka M; Blume C; Aker S; Kuhr N; Grabensee B; Ivens K
Clin Transplant; 2007; 21(5):615-21. PubMed ID: 17845635
[TBL] [Abstract][Full Text] [Related]
6. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
[TBL] [Abstract][Full Text] [Related]
7. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection.
Pawlik A; Domanski L; Rozanski J; Florczak M; Dabrowska-Zamojcin E; Dutkiewicz G; Gawronska-Szklarz B
Transplant Proc; 2005 Jun; 37(5):2041-3. PubMed ID: 15964333
[TBL] [Abstract][Full Text] [Related]
8. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis.
Rueda B; González-Gay MA; Mataran L; López-Nevot MA; Martín J
Tissue Antigens; 2005 Jun; 65(6):544-8. PubMed ID: 15896202
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft.
Striz I; Krasna E; Honsova E; Lacha J; Petrickova K; Jaresova M; Lodererova A; Bohmova R; Valhova S; Slavcev A; Vitko S
Immunol Lett; 2005 Jun; 99(1):30-5. PubMed ID: 15894108
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 promoter polymorphisms in patients with Behçet's disease.
Lee YJ; Kang SW; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Hum Immunol; 2006 Oct; 67(10):812-8. PubMed ID: 17055358
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes.
Mojtahedi Z; Naeimi S; Farjadian S; Omrani GR; Ghaderi A
Diabet Med; 2006 Mar; 23(3):235-9. PubMed ID: 16492204
[TBL] [Abstract][Full Text] [Related]
13. The cytokine gene polymorphisms in patients with chronic kidney graft rejection.
Pawlik A; Domanski L; Rozanski J; Florczak M; Wrzesniewska J; Dutkiewicz G; Dabrowska-Zamojcin E; Gawronska-Szklarz B
Transpl Immunol; 2005 Mar; 14(1):49-52. PubMed ID: 15814282
[TBL] [Abstract][Full Text] [Related]
14. RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection.
Krüger B; Böger CA; Obed A; Farkas S; Hoffmann U; Banas B; Fischereder M; Krämer BK
Clin Transplant; 2007; 21(3):385-90. PubMed ID: 17488389
[TBL] [Abstract][Full Text] [Related]
15. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation.
Brabcova I; Petrasek J; Hribova P; Hyklova K; Bartosova K; Lacha J; Viklický O
Transplantation; 2007 Oct; 84(8):1037-44. PubMed ID: 17989610
[TBL] [Abstract][Full Text] [Related]
17. Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-gamma in relation to acute rejection and graft vascular disease after clinical heart transplantation.
Holweg CT; Peeters AM; Balk AH; Uitterlinden AG; Niesters HG; Maat AP; Weimar W; Baan CC
Transpl Immunol; 2003; 11(1):121-7. PubMed ID: 12727483
[TBL] [Abstract][Full Text] [Related]
18. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults.
Novota P; Kolostova K; Pinterova D; Novak J; Treslova L; Andel M; Cerna M
Immunol Lett; 2005 Jan; 96(2):247-51. PubMed ID: 15585330
[TBL] [Abstract][Full Text] [Related]
19. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study.
Gendzekhadze K; Rivas-Vetencourt P; Montano RF
Transpl Immunol; 2006 Nov; 16(3-4):194-9. PubMed ID: 17138053
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
